MariMed Inc. (MRMD)
OTCMKTS: MRMD · Delayed Price · USD
0.460
+0.005 (1.08%)
Jun 24, 2022 4:00 PM - Market closed
Company Description
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally.
The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand.
It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
MariMed Inc.

Country | United States |
Industry | Drug Manufacturers-Specialty & Generic |
Sector | Health Care |
Employees | 260 |
Contact Details
Address:
10 Oceana Way Norwood, MA 02062 United States | |
Phone | 617 795 5140 |
Stock Details
Ticker Symbol | MRMD |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | US Dollars |
CIK Code | 1522767 |
Key Executives
Name | Position |
---|---|
Robert N. Fireman | Co-Founder, Chairman, President and Chief Executive Officer |
Jon R. Levine | Co-Founder, Chief Administrative Officer, Secretary and Director |
Timothy Shaw | Chief Operating Officer |
Susan Villare CPA | Chief Financial Officer |
Jonathan W. Rider | Chief Information Officer |
Steve Wayne West | Vice President of Investor Relations |
Howard Schacter | Chief Communications Officer |
Sara Gullickson | Vice President of Marketing |
Ryan Crandall | Senior Vice President of Sales and Chief Product Officer |
Charles Holt Finnie | Chief Strategy Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 18, 2022 | 3 | Initial statement of beneficial ownership of securities |
May 18, 2022 | 8-K | Current report |
May 16, 2022 | 8-K | Current report |
May 10, 2022 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
Apr 14, 2022 | 8-K | Current report |
Mar 21, 2022 | 8-K | Current report |
Mar 16, 2022 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] |
Jan 14, 2022 | 4 | Statement of changes in beneficial ownership of securities |
Jan 14, 2022 | 4 | Statement of changes in beneficial ownership of securities |
Jan 5, 2022 | 8-K | Current report |